Everything below concerns LC-MS/MS. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-06-15. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical chemists detect SR9009 with liquid chromatography-tandem mass spectrometry, commonly abbreviated LC-MS/MS. Sample preparation may involve protein precipitation, liquid-liquid extraction, or solid-phase extraction before analysis. Laboratories can target the parent compound or its metabolites, depending on the matrix and the purpose of testing. Anti-doping methods require sensitive and specific assays because concentrations in biological samples can be low. Reference standards and validated methods are essential for reliable identification and quantification.
Regulatory agencies have not approved SR9009 for human therapeutic use. It is typically sold as a research chemical with labels stating that it is not for human consumption. The World Anti-Doping Agency prohibits the substance in sport, generally under the category of non-approved substances. Customs and national laws may restrict importation, sale, or possession. Product quality and legal status can vary by country and vendor, and therapeutic claims are not permitted in regulated advertising because the compound lacks approval.
Several misconceptions surround SR9009. It is often described as a SARM, a steroid, or an exercise pill, but its known target is the REV-ERB receptor family. Rodent studies have examined exercise capacity and metabolic markers, yet human outcomes remain unproven. Oral bioavailability appears low in animals, and human pharmacokinetics are not well characterized. Online products may contain impurities or different compounds, so identity and purity testing are important for research use.
Mechanistically, SR9009 binds the ligand-binding domain of REV-ERBα/β and enhances recruitment of corepressor complexes. This represses target genes rather than activating them. Because REV-ERB proteins normally compete with ROR proteins at shared response elements, the net effect depends on tissue and timing. Researchers use SR9009 to probe how nuclear receptor signaling links the clock to metabolism, inflammation, and muscle biology. Findings are largely preclinical, and the precise contribution of each receptor subtype remains under study.
SR9009 is frequently discussed in fitness and research-chemical contexts, yet it has no approved medical indication. Regulatory agencies have not authorized it for human use, and it is not a standard prescription drug. Some sports organizations list it as a prohibited substance because of its potential performance-enhancing properties. Published human data are sparse, so claims about its effects in people often rely on animal models or anecdotal reports. Quality and identity of online materials can vary widely.
SR9009 is a synthetic small molecule studied as a REV-ERB agonist. REV-ERBα and REV-ERBβ are nuclear receptors that help regulate circadian rhythms and metabolic gene expression. The compound was identified in academic screening efforts to find synthetic ligands for these receptors. In cell and animal studies, SR9009 alters transcription of genes involved in lipid and glucose metabolism, and it can shift circadian behavior. It is not an approved therapeutic agent.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Not approved for human use | Research-use-only status in many markets |
| WADA status | Prohibited in sport | Generally listed as a non-approved substance |
| Detection technique | LC-MS/MS | Common for urine and blood analysis |
| Common alias | Stenabolic | Informal market nickname, not a pharmacopoeial name |
| Purity check | HPLC or LC-UV | Independent certificate of analysis is typical |
Regulatory status varies by country and intended use. Major drug agencies have not granted marketing authorization for SR9009 as a medicine, and it is not listed as a controlled substance in many jurisdictions. It is often sold as a research chemical, a category that may fall outside pharmaceutical manufacturing rules. Buyers should verify local laws and supplier documentation, including certificates of analysis. The lack of standardized quality controls raises concerns about identity, purity, and actual content in products marketed online.
In laboratory settings, SR9009 is commonly identified by its molecular structure and its interaction with REV-ERB receptors. Vendors may list it under synonyms such as Stenabolic or REV-ERB agonist, but those names do not define purity or identity. Analytical confirmation typically uses high-performance liquid chromatography with ultraviolet detection or liquid chromatography–mass spectrometry. A reference standard is needed to compare retention time and mass spectrum, because the compound can be confused with related research chemicals.
Handling practices for SR9009 focus on minimizing degradation and contamination. The solid is generally stored desiccated at or below -20 °C, protected from light and moisture. Stock solutions are often prepared in dimethyl sulfoxide or ethanol, then aliquoted to avoid repeated freeze–thaw cycles. Aqueous solubility is low, so formulations for animal studies may require cosolvents or suspending agents. Personnel should follow institutional chemical safety procedures, because toxicological data for humans are incomplete.
REV-ERB proteins typically suppress gene expression by recruiting corepressor complexes to DNA response elements. SR9009 binds these receptors and strengthens that repressive action in cell-based assays. Studies in rodents have reported changes in lipid handling, mitochondrial function, and exercise capacity after treatment. Such findings are often cited as evidence for metabolic effects, but species differences and limited pharmacokinetic data make direct translation to humans uncertain. Researchers continue to examine which effects are robust and which depend on specific experimental conditions.
SR9009 is frequently discussed alongside other REV-ERB ligands, including synthetic agonists and natural heme-related molecules. Its selectivity for REV-ERB over related nuclear receptors has been measured in binding and reporter assays, though off-target activity at higher concentrations is possible. The compound is prohibited in sport by the World Anti-Doping Agency, and it is not approved for any medical use in major jurisdictions. Products sold online may be labeled as research chemicals, and their identity and purity are not guaranteed by regulatory review.
=== Dance === Bromley has its own team of Morris dancers, The Ravensbourne Morris Men, founded in 1947 as a post-war revival team following an inaugural meeting at the then Jean's Café, which was located opposite Bromley South Station.
The meta-analysis, which pooled published results of five large clinical trials, also found that the treatment cut the rate of breathing problems and reduced the need for placing a baby on a ventilator.
=== Nervous system === Microglia are the resident immune cells of the central nervous system (i.e., brain and spinal cord). They are key contributors to the development and maintenance of neural tissues and mediate inflammatory responses to, e.g., bacterial invasion as well as the pathological inflammations which underlie many neurological diseases. Studies have reported that compared to control mice, germ-free mice (which lack SCFAs in their gastrointestinal tracts) have increased levels of immature microglia throughout their brains; SCFA supplementation normalized the microglial cell maturity. Furthermore, Ffar2 gene knockout mice likewise had increased levels of immature microglia throughout their brains. These studies suggest that FFAR2 is required for the maturation, and therefore functionality, of the microglia in mice. Since mouse microglial cells do not express FFAR2, the FFAR2-bearing cells responsible for the maturation and thereby functionality of the mouse's microglia are unclear. Studies have suggested that promoting the intestinal microbiota's production of SCFAs may suppress the development and/or progression of various human neurological diseases, particularly Parkinson's disease, Alzheimer's disease, neuromyelitis optica, and multiple sclerosis. This linkage is thought to involve at least in part SCFA-induced suppression of the inflammation associated with these diseases.
Colombian literature dates back to pre-Columbian era; a notable example of the period is the epic poem known as the Legend of Yurupary. In Spanish colonial times, notable writers include Juan de Castellanos (Elegías de varones ilustres de Indias), Hernando Domínguez Camargo and his epic poem to San Ignacio de Loyola, Pedro Simón and Juan Rodríguez Freyle. Post-independence literature linked to Romanticism highlighted Antonio Nariño, José Fernández Madrid, Camilo Torres Tenorio and Francisco Antonio Zea. In the second half of the nineteenth century and early twentieth century the literary genre known as costumbrismo became popular; great writers of this period were Tomás Carrasquilla, Jorge Isaacs and Rafael Pombo (the latter of whom wrote notable works of children's literature). Within that period, authors such as José Asunción Silva, José Eustasio Rivera, León de Greiff, Porfirio Barba-Jacob and José María Vargas Vila developed the modernist movement. In 1872, Colombia established the Colombian Academy of Language, the first Spanish language academy in the Americas. Candelario Obeso wrote the groundbreaking Cantos Populares de mi Tierra (1877), the first book of poetry by an Afro-Colombian author. Between 1939 and 1940 seven books of poetry were published under the name Stone and Sky in the city of Bogotá that significantly influenced the country; they were edited by the poet Jorge Rojas.
Sources: en.wikipedia.org
Wu (吴语): Jiangzhe people (江浙民系) Hui (徽语): Wannan people (皖南民系) Gan (赣语): Jiangxi people (江西民系) Xiang (湘语): Hunan people (湖南民系) Min (闽语): Minhai people (闽海民系) Hakka (客语): Hakka people (客家民系) Yue (粤语): Cantonese people (岭南民系) Pinghua (平话) and Tuhua (土话): Pingnan people (平南民系) Jin (晋语): Jinsui people (晋绥民系) Mandarin (官话): Northern people (北方民系) Northeastern (东北): Northeastern people (东北民系) Beijing (北平): Youyan people (幽燕民系) Jilu (冀鲁): Jilu people (冀鲁民系) Jiaoliao (胶辽): Jiaoliao people (胶辽民系) Central Plains (中原): Central Plains people (中原民系) Lanyin (兰银): Longyou people (陇右民系) Southwestern (西南): Southwestern people (西南民系) Jianghuai (江淮): Jianghuai people (江淮民系)
Anthony Tiran Todd (December 4, 1954 – November 6, 2024) was an American actor. Known for his distinctly deep and gravelly voice, he amassed numerous credits on screen and in video games since the 1980s, including the title character in the Candyman film series (1992–2021) and William Bludworth in the Final Destination franchise (2000–2025). For the former, he was nominated at the Critics' Choice and Fangoria Chainsaw Awards. Todd's films include Platoon (1986), Night of the Living Dead (1990), The Crow (1994), The Rock (1996), Wishmaster (1997), Hatchet, Minotaur (both 2006), The Man from Earth (2007), Frankenstein (2015), Death House (2017), and Hell Fest (2018). On television, he played Kurn in Star Trek: The Next Generation (1990–1991) and Star Trek: Deep Space Nine (1996), Lord Haikon on Stargate SG-1 (2005–2006), and appeared in the MTV series Scream (2019) and Devil May Cry (2025). Todd was a prolific voice actor, notably voicing the Vortigaunts in the Half-Life series of games, the Fallen in Michael Bay's Transformers: Revenge of the Fallen (2009), Zoom in The Flash (2014–2023), Darkseid in the DC Animated Movie Universe (2015–2020), Venom in the video game Marvel's Spider-Man 2 (2023), and Locus in the video game Indiana Jones and the Great Circle (2024). For Spider-Man 2, he received a British Academy Games Award nomination.
== As controlled drug == Thebaine is controlled under international law, is listed as a Class A drug under the Misuse of Drugs Act 1971 in the United Kingdom, is controlled as an analog of a Schedule II drug per the Analog Act in the United States, and is controlled with its derivatives and salts, as a Schedule I substance of the Controlled Drugs and Substances Act in Canada. The 2013 US Drug Enforcement Administration (DEA) aggregate manufacturing quota for thebaine (ACSCN 9333) was unchanged from the previous year at 145 metric tons.
== Early history == In the Early Middle Ages, Cumbria was part of the Kingdom of Strathclyde in the Hen Ogledd, or "Old North", and its people spoke a Brittonic language now called Cumbric. The first record of the term Cumberland appears in AD 945, when the Anglo-Saxon Chronicle recorded that the area was ceded to Malcolm I, king of Alba (Scotland), by King Edmund I of England. As with Cymru, the native Welsh name for Wales, the names Cumberland and Cumbria are derived from kombroges in Common Brittonic, which originally meant 'compatriots'. At the time of the Domesday Book (AD 1086) most of the future county was part of Scotland, although some villages around Millom, which were the possessions of the Earl of Northumbria, had been incorporated into Yorkshire. In AD 1092, King William Rufus of England invaded the Carlisle district, settling it with colonists. He created an Earldom of Carlisle, and granted the territory to Ranulf le Meschin. In 1133, Carlisle was made the see of a new diocese, largely identical with the area of the earldom. However, on the death of King Henry I of England in 1135, the area was regained by King David I of Scotland. He was able to consolidate his power and made Carlisle one of his chief seats of government, while England descended into a lengthy civil war. The Cumbric language is believed to have become extinct in the 12th century.
=== 1970s === In 1970, Grace purchased FAO Schwartz. In the following year, Grace acquired the Italian food company Barilla. In that same year, Grace reported 1971 earnings of $2 billion and was 47th largest industrial in the Fortune 500 survey for that year. In 1972, W. R. Grace signed a 30-year lease for its new headquarters at the building that would become known as the W.R. Grace Building. In 1977, Grace purchased Del Taco Restaurants, Incorporated. In 1978, the proposed merger of Grace and King's Department Stores was called off. The addition of the department stores would have added $325 million in sales revenue to what was $1 billion in revenue from restaurants and retail for Grace at that time.
Sources: en.wikipedia.org
Legality depends on the country and the intended use. In many places it is not approved as a medicine and may be sold only as a research chemical. Importation or possession can be restricted, and sports organizations prohibit it.
Anti-doping laboratories typically use LC-MS/MS to detect SR9009 or its metabolites in urine or blood. The exact assay depends on the laboratory and the testing program. Detection can be challenging because the compound may be rapidly metabolized and present at low levels.
Stenabolic is an informal nickname used in online fitness and research-chemical markets, not an official drug name. It likely references reported effects on endurance in rodent studies. The nickname does not imply approval or proven human benefit.
SR9009 is a synthetic compound investigated as an agonist of the nuclear receptors REV-ERBα and REV-ERBβ. It is used in preclinical research on circadian rhythm and metabolism. It is not an approved drug.